CASH, CASH EQUIVALENTS AND INVESTMENTS

Cadence’s cash, cash equivalents and short-term investments at fair value as of December 30, 2017 and December 31, 2016 were as follows:



	As of
	December 30, 2017		December 31, 2016
	(In thousands)
Cash and cash equivalents	$	688,087	$	465,232
Short-term investments	4,455		3,057
Cash, cash equivalents and short-term investments	$	692,542	$	468,289

Cash and Cash Equivalents

The following table summarizes Cadence’s cash and cash equivalents at fair value as of December 30, 2017 and December 31, 2016:



	As of
	December 30, 2017		December 31, 2016
	(In thousands)
Cash and interest bearing deposits	$	184,153	$	227,508
Money market funds	503,934		237,724
Total cash and cash equivalents	$	688,087	$	465,232

Short-Term Investments

The following tables summarize Cadence’s short-term investments as of December 30, 2017 and December 31, 2016:



	As of December 30, 2017
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
	(In thousands)
Marketable equity securities	$	1,817	$	2,638	$	—	$	4,455



	As of December 31, 2016
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
	(In thousands)
Marketable equity securities	$	2,131	$	926	$	—	$	3,057

Realized gains and losses from the sale of marketable equity securities are recorded in other income, net in the consolidated income statements.

Non-Marketable Investments

Cadence’s non-marketable investments generally consist of voting preferred stock, convertible debt or other instruments of privately-held entities and are included in other assets on Cadence’s consolidated balance sheets. If Cadence determines that it has the ability to exercise significant influence over the issuer, which may include considering whether the investments are in-substance common stock, the investment is accounted for using the equity method. The equity method income or loss recorded by Cadence is based on its percentage ownership in the issuer.

Cadence records realized gains and losses from the sale of non-marketable investments and write-downs related to cost method investments due to other-than-temporary declines in value in the consolidated income statements as other income, net.

Cadence’s non-marketable investments as of December 30, 2017 and December 31, 2016 were as follows:



	As of
	December 30, 2017		December 31, 2016
	(In thousands)
Cost method	$	532	$	532
Equity method	2,460		2,634
Total non-marketable investments	$	2,992	$	3,166